These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 18472202)
1. The association of genotypic combination of the DRD3 and BDNF polymorphisms on the adhesio interthalamica and medial temporal lobe structures. Takahashi T; Suzuki M; Tsunoda M; Kawamura Y; Takahashi N; Maeno N; Kawasaki Y; Zhou SY; Hagino H; Niu L; Tsuneki H; Kobayashi S; Sasaoka T; Seto H; Kurachi M; Ozaki N Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1236-42. PubMed ID: 18472202 [TBL] [Abstract][Full Text] [Related]
2. Association between the brain-derived neurotrophic factor Val66Met polymorphism and brain morphology in a Japanese sample of schizophrenia and healthy comparisons. Takahashi T; Suzuki M; Tsunoda M; Kawamura Y; Takahashi N; Tsuneki H; Kawasaki Y; Zhou SY; Kobayashi S; Sasaoka T; Seto H; Kurachi M; Ozaki N Neurosci Lett; 2008 Apr; 435(1):34-9. PubMed ID: 18325670 [TBL] [Abstract][Full Text] [Related]
3. Association between absence of the adhesio interthalamica and amygdala volume in schizophrenia. Takahashi T; Suzuki M; Nakamura K; Tanino R; Zhou SY; Hagino H; Niu L; Kawasaki Y; Seto H; Kurachi M Psychiatry Res; 2008 Feb; 162(2):101-11. PubMed ID: 18226506 [TBL] [Abstract][Full Text] [Related]
4. Genetic study of BDNF, DRD3, and their interaction in tardive dyskinesia. Zai CC; Tiwari AK; De Luca V; Müller DJ; Bulgin N; Hwang R; Zai GC; King N; Voineskos AN; Meltzer HY; Lieberman JA; Potkin SG; Remington G; Kennedy JL Eur Neuropsychopharmacol; 2009 May; 19(5):317-28. PubMed ID: 19217756 [TBL] [Abstract][Full Text] [Related]
5. Effects of brain-derived neurotrophic factor Val66Met polymorphism on hippocampal volume change in schizophrenia. Koolschijn PC; van Haren NE; Bakker SC; Hoogendoorn ML; Hulshoff Pol HE; Kahn RS Hippocampus; 2010 Sep; 20(9):1010-7. PubMed ID: 19714565 [TBL] [Abstract][Full Text] [Related]
6. The BDNF Val66Met polymorphism impacts parahippocampal and amygdala volume in healthy humans: incremental support for a genetic risk factor for depression. Montag C; Weber B; Fliessbach K; Elger C; Reuter M Psychol Med; 2009 Nov; 39(11):1831-9. PubMed ID: 19335934 [TBL] [Abstract][Full Text] [Related]
7. Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression. Frodl T; Schüle C; Schmitt G; Born C; Baghai T; Zill P; Bottlender R; Rupprecht R; Bondy B; Reiser M; Möller HJ; Meisenzahl EM Arch Gen Psychiatry; 2007 Apr; 64(4):410-6. PubMed ID: 17404118 [TBL] [Abstract][Full Text] [Related]
8. Interaction of the DRD3 and BDNF gene variants in subtyped bipolar disorder. Lee SY; Chen SL; Chen SH; Chu CH; Chang YH; Lin SH; Huang SY; Tzeng NS; Kuo PH; Lee IH; Yeh TL; Yang YK; Lu RB Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):382-7. PubMed ID: 22877924 [TBL] [Abstract][Full Text] [Related]
9. Association of polymorphisms in the BDNF, DRD1 and DRD3 genes with tobacco smoking in schizophrenia. Novak G; LeBlanc M; Zai C; Shaikh S; Renou J; DeLuca V; Bulgin N; Kennedy JL; Le Foll B Ann Hum Genet; 2010 Jul; 74(4):291-8. PubMed ID: 20456319 [TBL] [Abstract][Full Text] [Related]
10. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms. Numata S; Ueno S; Iga J; Yamauchi K; Hongwei S; Ohta K; Kinouchi S; Shibuya-Tayoshi S; Tayoshi S; Aono M; Kameoka N; Sumitani S; Tomotake M; Kaneda Y; Taniguchi T; Ishimoto Y; Ohmori T Neurosci Lett; 2006 Jun; 401(1-2):1-5. PubMed ID: 16533563 [TBL] [Abstract][Full Text] [Related]
11. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers. Ho BC; Milev P; O'Leary DS; Librant A; Andreasen NC; Wassink TH Arch Gen Psychiatry; 2006 Jul; 63(7):731-40. PubMed ID: 16818862 [TBL] [Abstract][Full Text] [Related]
12. Multiple variants of the DRD3, but not BDNF gene, influence age-at-onset of schizophrenia. Renou J; De Luca V; Zai CC; Bulgin N; Remington G; Meltzer HY; Lieberman JA; Le Foll B; Kennedy JL Mol Psychiatry; 2007 Dec; 12(12):1058-60. PubMed ID: 18043709 [No Abstract] [Full Text] [Related]
13. Brain-derived neurotrophic factor polymorphisms and frontal cortex morphology in schizophrenia. Varnäs K; Lawyer G; Jönsson EG; Kulle B; Nesvåg R; Hall H; Terenius L; Agartz I Psychiatr Genet; 2008 Aug; 18(4):177-83. PubMed ID: 18628679 [TBL] [Abstract][Full Text] [Related]
14. Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation. Szeszko PR; Lipsky R; Mentschel C; Robinson D; Gunduz-Bruce H; Sevy S; Ashtari M; Napolitano B; Bilder RM; Kane JM; Goldman D; Malhotra AK Mol Psychiatry; 2005 Jul; 10(7):631-6. PubMed ID: 15768049 [TBL] [Abstract][Full Text] [Related]
15. The Disrupted-in-Schizophrenia-1 Ser704Cys polymorphism and brain morphology in schizophrenia. Takahashi T; Suzuki M; Tsunoda M; Maeno N; Kawasaki Y; Zhou SY; Hagino H; Niu L; Tsuneki H; Kobayashi S; Sasaoka T; Seto H; Kurachi M; Ozaki N Psychiatry Res; 2009 May; 172(2):128-35. PubMed ID: 19304459 [TBL] [Abstract][Full Text] [Related]
16. Adhesio interthalamica in individuals at high-risk for developing psychosis and patients with psychotic disorders. Takahashi T; Yücel M; Yung AR; Wood SJ; Phillips LJ; Berger GE; Ang A; Soulsby B; McGorry PD; Suzuki M; Velakoulis D; Pantelis C Prog Neuropsychopharmacol Biol Psychiatry; 2008 Oct; 32(7):1708-14. PubMed ID: 18675876 [TBL] [Abstract][Full Text] [Related]
17. Association study of BDNF and DRD3 genes in schizophrenia diagnosis using matched case-control and family based study designs. Zai CC; Manchia M; De Luca V; Tiwari AK; Squassina A; Zai GC; Strauss J; Shaikh SA; Freeman N; Meltzer HY; Lieberman J; Le Foll B; Kennedy JL Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec; 34(8):1412-8. PubMed ID: 20667458 [TBL] [Abstract][Full Text] [Related]
18. Effect of the brain-derived neurotrophic factor and the apolipoprotein E polymorphisms on disease progression in preclinical Alzheimer's disease. Hashimoto R; Hirata Y; Asada T; Yamashita F; Nemoto K; Mori T; Moriguchi Y; Kunugi H; Arima K; Ohnishi T Genes Brain Behav; 2009 Feb; 8(1):43-52. PubMed ID: 18786162 [TBL] [Abstract][Full Text] [Related]
19. The Val66Met polymorphism of the brain-derived neurotrophic factor gene affects age-related brain morphology. Nemoto K; Ohnishi T; Mori T; Moriguchi Y; Hashimoto R; Asada T; Kunugi H Neurosci Lett; 2006 Apr 10-17; 397(1-2):25-9. PubMed ID: 16388901 [TBL] [Abstract][Full Text] [Related]
20. Brain-derived neurotrophic factor Val66Met polymorphism and obsessive-compulsive symptoms in Egyptian schizophrenia patients. Hashim HM; Fawzy N; Fawzi MM; Karam RA J Psychiatr Res; 2012 Jun; 46(6):762-6. PubMed ID: 22521161 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]